Back to results
US 11,236,157 B2Granted
Treatment of skin lesions and pruritus in prurigo nodularis patients
AssigneeGalderma Holding SA
InventorChristophe Piketty
Life of this patent
Estimating the term…
Abstract
Disclosed herein are methods for selectively treating pruritus in a subject having chronic prurigo (CP), including prurigo nodularis (PN), pharmaceutical compositions for use in the treatment of pruritus in a subject having CP or PN, uses of nemolizumab or an equivalent thereof in the manufacture of a medicament for the treatment of pruritus in a subject having CP or PN.
Claims25
A method of treating skin lesions and pruritus in a subject having chronic prurigo (CP), the method comprising administering an effective amount of nemolizumab or an equivalent thereof to the subject, wherein the subject does not have atopic dermatitis.
Dependencies are inferred from the claim text.